Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New stroke drug aims to stop clots from coming back

NCT ID NCT07335107

Summary

This study is testing if adding a blood-thinning drug called tirofiban helps people recover better after they've had emergency treatment for a severe stroke. It will involve 564 patients in China who have just had a major stroke caused by a blocked artery. The main goal is to see if patients who get this extra drug are more likely to be independent 90 days later, compared to those who get standard care alone.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Beijing Tiantan Hospital, Capital Medical University

    Beijing, Beijing Municipality, 100070, China

Conditions

Explore the condition pages connected to this study.